DOCPHARMA
ActiveSummary
DOCPHARMA has been active since 1999 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €36.6m and a net result of €581,444. Equity remains stable across the filed financial years (±1.4% per year). The computed 12-month bankruptcy probability is 0.3% (very low).
Directors
Board 3
6 not recently confirmed
Day-to-day management 1
Permanent representatives 1
Statutory auditor 1
Mandate history
- Board
- Day-to-day management
- Statutory auditor
- Other function
- not recently confirmed
- began earlier
| Name | Functions and periods |
|---|---|
| Matthew Salzmann |
|
| Tomasz Buczek |
|
| ArunNarayan |
|
| Deloitte Bedrijfsrevisoren/Réviseurs d’Entreprises |
|
| Anthony Herbert Bloom |
|
| Edward Borkowski |
|
| Robert Coury |
|
| Barret Didier Henri |
|
| Bouldoires Vincent Pierre |
|
| Bresch Heather Mangrin |
|
| Van Rompay Management |
|
| MatthewSalzmann |
|
| Vincent Verschraegen |
|
| Luis Birbuet |
|
| José Cotarelo |
|
| Anthonius van 't Hullenaar |
|
| Maximilian von Wülfing |
|
| Jens Neuschaefer |
|
| Yves Brigode |
|
| Khadija Badli |
|
| Gary Sphar |
|
| Mylan BVBA |
|
| Pascale Engelen |
|
| Didier Barret |
|
| Heather Bresch |
|
| Bouldoires Vincent |
|
| Malik Rajiv |
|
| Seshan Srinivasan |
|
| Nimmagadda Prasad |
|
| C Ramakrishna |
|
| C.S Murali |
|
| Matrix Laboratories NV |
|
| Etienne Lenoir |
|
| Maarten Coolen |
|
Owners and capital
Owners
1 ownerChain of control
- Viatris GX
- DOCPHARMA
Highest known parent: Viatris GX. The sources do not say who stands above it.
Owners 1
-
100%
According to the 2025 annual accounts of DOCPHARMA and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Capital and shareholders
- 25-02-2010 Capital stated in the act · €57,578,062.74 · 6,297,570 shares